[1] 孟海燕,寇学俊,周国,等. 低剂量替格瑞洛对急性冠脉综合征患者血小板聚集率及出血的响[J].山东医药,2017,57(33):67-70.
[2] 张红心,吴平平,李广平,等.PCI术前强化辛伐他汀治疗对急性冠脉综合征患者术后相关指标的影响[J].中国药房杂志,2017,28(12):1637-1640.
[3] 艳杰,孙冬冬,李伟杰,等.替格瑞洛联合强化阿托伐他汀在非ST抬高型急性冠脉综合征治疗中的安全性与有效性分析[J].陕西医学杂志,2017,46(6):793-795.
[4] 蒋建东,赵祥海,陈燕春,等.短程大剂量瑞舒伐他汀对急性冠脉综合征患者血糖和血脂代谢的影响[J].中西医结合心脑血管病杂志,2015,13(10):1197-1198.
[5] 中国医师协会急诊医师分会.急性冠脉综合征急诊快速诊疗指南[J]. 中华急诊医学杂志,2016,25(4):397-400.
[6] Di Sciascio G Patti G Pasceri V’et a1.Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:Results of the armyda.recapture fatorvastatin for reduction of myocardial damage during angioplastyl randomized trial[J].J Am Coll Cardiol,2014,54(6):558-565.
[7] Patti G, Pasceri V, Colonna G, et a1.Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention:Results of the ARMYDA.ACS randomized trial[J].J Am Coll Cardiol,2015,49(12):1272-1278.
[8] 王琰淏.瑞舒伐他汀联合替格瑞洛对急性冠脉综合征患者PCI 术后血脂水平及MACE发生率的影响[J].数理医学杂志,2018,31(12):1847-1850.
[9] 李永慧,王小玲,张玲玲,等.强化剂量瑞舒伐他汀联合替格瑞洛对急性冠脉综合征患者术后心功能及ICAM1、TIMP-1水平的影响[J].中国医师杂志,2019,21(10):1523-1525. |
